Monitor for further reductions or conversion to a 13D filing if Alta's intent shifts. The drop below 5% removes the filing obligation, so future exits may go unreported.
Price Chart
Executive Summary
Alta Partners LLC filed an amended Schedule 13G disclosing a 4.9% passive stake in Sunshine Biopharma Inc., consisting of 200,000 shares of common stock issuable upon exercise of outstanding warrants. The filing indicates a reduction from a prior stake above 5%, as the current beneficial ownership is below the 5% threshold, signaling a potential partial exit.
Key Financial Metrics
Key Facts
- Alta Partners LLC reported beneficial ownership of 200,000 shares of common stock, all issuable upon exercise of warrants.
- The stake represents 4.9% of outstanding shares, down from a prior position above 5%.
- The filing is an amendment to Schedule 13G, confirming passive intent under Rule 13d-1(c).
- Date of event triggering filing: August 13, 2026.
- Alta Partners LLC is a New York limited liability company with business address in Garden City, NY.
Financial Impact
Stake reduced to 4.9% from above 5% — no dollar value disclosed.
Risk Factors
- Potential further selling by Alta Partners if warrants are exercised and shares sold.
- Loss of a significant passive holder could reduce liquidity and signal waning institutional interest.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001094891-26-000296 |
| Document: 0001094891-26-000296-index.html | 0001094891-26-000296 |
| Document: 0001094891-26-000296.txt | 0001094891-26-000296 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | SC 13G | $0.2430 $0.2154 | ▼ −11.36% | ▼ −11.81% | $2.65 (+990.54%) |
Oct 13, 2026 13d ago | SC 13G | $0.2430 $0.2154 | ▼ −11.36% | ▼ −11.81% | $2.65 (+990.54%) |
Oct 9, 2026 17d ago | 8-K | $0.3020 $0.2418 | ▲ +19.93% | ▲ +18.44% | $2.65 (−777.48%) |
Oct 9, 2026 17d ago | 424B4 | $0.3020 $0.2418 | ▲ +19.93% | ▲ +18.44% | $2.65 (−777.48%) |
Oct 8, 2026 19d ago | EFFECT | $0.4300 $0.2300 | ▲ +46.51% | ▲ +46.24% | $2.65 (−516.28%) |
Oct 5, 2026 21d ago | SC 13G/A | $0.3979 $0.2363 | ▲ +40.61% | ▲ +40.47% | $2.65 (−566.00%) |
Oct 2, 2026 24d ago | S-1 | $0.4201 $0.3020 | ▲ +28.11% | ▲ +28.53% | $2.65 (−530.80%) |
Sep 9, 2026 6w ago | EFFECT | $1.12 $1.04 | ▲ +7.59% | ▲ +7.26% | $2.65 (−136.61%) |
Aug 28, 2026 8w ago | 8-K | $1.12 $1.15 | ▲ +2.68% | ▲ +2.82% | $2.65 (+136.61%) |
Aug 3, 2026 12w ago | 8-K | $23.40 $24.40 | ▲ +4.27% | ▲ +2.25% | $2.65 (−88.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers